NCT00227110: Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH) |
|
|
| Completed | 4 | 55 | US | Pioglitazone, Actos (Takeda Pharmaceuticals)., Placebo | The University of Texas Health Science Center at San Antonio, National Institutes of Health (NIH), Takeda Pharmaceuticals North America, Inc. | Nonalcoholic Steatohepatitis | 11/05 | 01/06 | | |
